Chiba University is a national university in the city of Chiba, Japan. It offers Doctoral degrees in education as part of a coalition with Tokyo Gakugei University, Saitama University, and Yokohama National University.

During the past decade, Chiba University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chiba University" #1 sponsor was "Chiba University" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 1 trials sponsored, "University of British Columbia" with 1 trials sponsored and "University of Oxford" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chiba University" #1 collaborator was "American College of Rheumatology" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "The European League Against Rheumatism (EULAR)" with 1 trials as a collaborator, "The Vasculitis foundation" with 1 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Chiba University" are "Bile Duct Cancer" (2 trials), "Heart Failure" (2 trials), "Churg Strauss Syndrome" (1 trials), "Colorectal Cancer" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Chiba University" in a lesser frequency.

Most popular intervention types in "Chiba University" are "Dietary Supplement" (3 trials), "Drug" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Oral IMPACT" (3 trials), "Azilsartan" (1 trials), "BiV/MPP" (1 trials), "CRT Patients" (1 trials) and "Candesartan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chiba University" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Chiba University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Chiba University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chiba University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Chiba University has several departments that took part in Clinical trials: "Department of Psychiatry, Chiba University School of Medicine" - 3 trials, "Chiba Children's Hospital" - 3 trials, "Chiba Heart Clinic" - 2 trials